Randomized controlled trial of Anshumati Ksheer Paka in hypertension induced left ventricular hypertrophy. - NI

Central Council For Research In Ayurvedic Sciences, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•2.Participants diagnosed with LVH having left ventricular mass index more than 115 g/m2 in men, and more than 95 g/m2 in women, as evidenced by echocardiography.
•3.Participants having mild to moderate Hypertension (grade 1 and 2)
•4.Participant willing and able to give informed consent.

•1.Left Ventricular Ejection Fraction less than 45% on screening echocardiography.
•2.History of myocardial infarction or stroke within 6 months
•3.History of Heart failure, ischemic heart disease, valvular heart disease, arrhythmias, peripheral vascular disease, history of any type of cardiac surgery.
•4.Renal dysfunction, chronic kidney disease (GFR less than 60 ml/min), Significant chronic renal impairment (Serum creatinine more than 2.0 mg/dL).
•5.Severe hypertension (Systolic BP more than or equal to 180 mm Hg or Diastolic BP more than or equal to 110 mm Hg).
•6.Diabetic patients with HbA1c more than 7%.
•7.Diagnosed Patients of Dyslipidemia having values of total Cholesterol (more than 240 mg/dl), Low Density Lipoprotein (LDL more than 160 mg/dl), Triglycerides (more than 200 mg/dl) and High Density Lipoprotein (HDL less than 40 mg/dl)
•8.Known cases of lactose intolerance.
•9.Participants who have participated in any other clinical trial within the previous 30 days.
•10.Pregnant/lactating females
•11.Participants with a history of substance abuse or alcohol abuse and smokers
•12.Any other condition which the P.I. thinks may jeopardize the study.

发起方

Central Council For Research In Ayurvedic Sciences, New Delhi